|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
GBD 2013 Mortality and Causes of Death
Collaborators: Global, regional, and national age-sex specific
all-cause and cause-specific mortality for 240 causes of death,
1990–2013: A systematic analysis for the Global Burden of Disease
Study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar
|
|
4
|
Miller YE: Pathogenesis of lung cancer:
100 year report. Am J Respir Cell Mol Biol. 33:216–223. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Syrigos KN, Katirtzoglou N, Kotteas E and
Harrington K: Adhesion molecules in lung cancer: Implications in
the pathogenesis and management. Curr Pharm Des. 14:2173–2183.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gazdar AF and Minna JD: Angiogenesis and
the multistage development of lung cancers. Clin Cancer Res.
6:1611–1612. 2000.PubMed/NCBI
|
|
7
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hodkinson PS, Mackinnon A and Sethi T:
Targeting growth factors in lung cancer. Chest. 133:1209–1216.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sethi T and Woll PJ: Growth factors and
lung cancer. Cancer Treat Res. 72:111–130. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bradley JR and Pober JS: Tumor necrosis
factor receptor-associated factors (TRAFs). Oncogene. 20:6482–6491.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung JY, Park YC, Ye H and Wu H: All
TRAFs are not created equal: Common and distinct molecular
mechanisms of TRAF-mediated signal transduction. J Cell Sci.
115:679–688. 2002.PubMed/NCBI
|
|
12
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun H, Li X, Fan L, Wu G, Li M and Fang J:
TRAF6 is upregulated in colon cancer and promotes proliferation of
colon cancer cells. Int J Biochem Cell Biol. 53:195–201. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng Z, Shuangzhu Y, Yongjie J, Xinjun Z
and Ying L: TNF receptor-associated factor 6 regulates
proliferation, apoptosis, and invasion of glioma cells. Mol Cell
Biochem. 377:87–96. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng Q, Zheng M, Liu H, Song C, Zhang W,
Yan J, Qin L and Liu X: TRAF6 regulates proliferation, apoptosis,
and invasion of osteosarcoma cell. Mol Cell Biochem. 371:177–186.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han Q, Yao F, Zhong C and Zhao H: TRAF6
promoted the metastasis of esophageal squamous cell carcinoma.
Tumour Biol. 35:715–721. 2014. View Article : Google Scholar
|
|
17
|
Bilir C, Engin H, Can M, Likhan S,
Demirtas D, Kuzu F and Bayraktaroglu T: Increased serum tumor
necrosis factor receptor-associated factor-6 expression in patients
with non-metastatic triple-negative breast cancer. Oncol Lett.
9:2819–2824. 2015.PubMed/NCBI
|
|
18
|
Zhang XL, Dang YW, Li P, Rong MH, Hou XX,
Luo DZ and Chen G: Expression of tumor necrosis factor
receptor-associated factor 6 in lung cancer tissues. Asian Pac J
Cancer Prev. 15:10591–10596. 2014. View Article : Google Scholar
|
|
19
|
Lin G and Huang C, Su G, Hu H, Xu H and
Huang C: Effect of TRAF6 downregulation on malignant biological
behavior of lung cancer cell lines. Zhongguo Fei Ai Za Zhi.
18:661–667. 2015.In Chinese. PubMed/NCBI
|
|
20
|
Zhong L, Cao F and You Q: Effect of TRAF6
on the biological behavior of human lung adenocarcinoma cell.
Tumour Biol. 34:231–239. 2013. View Article : Google Scholar
|
|
21
|
Starczynowski DT, Lockwood WW, Deléhouzée
S, Chari R, Wegrzyn J, Fuller M, Tsao MS, Lam S, Gazdar AF, Lam WL,
et al: TRAF6 is an amplified oncogene bridging the RAS and NF-κB
pathways in human lung cancer. J Clin Invest. 121:4095–4105. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Zhang T, Ye J, Li H, Huang J, Li X,
Wu B, Huang X and Hou J: TNF receptor-associated factor 6 in
advanced non-small cell lung cancer: Clinical and prognostic
implications. J Cancer Res Clin Oncol. 138:1853–1863. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen ZJ: Ubiquitin signalling in the
NF-kappaB pathway. Nat Cell Biol. 7:758–765. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
25
|
DiDonato JA, Mercurio F and Karin M: NF-κB
and the link between inflammation and cancer. Immunol Rev.
246:379–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karin M: NF-kappaB as a critical link
between inflammation and cancer. Cold Spring Harb Perspect Biol.
1:a0001412009. View Article : Google Scholar
|
|
28
|
Esencay M, Newcomb EW and Zagzag D: HGF
upregulates CXCR4 expression in gliomas via NF-kappaB: Implications
for glioma cell migration. J Neurooncol. 99:33–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ju JH, Jang K, Lee KM, Kim M, Kim J, Yi
JY, Noh DY and Shin I: CD24 enhances DNA damage-induced apoptosis
by modulating NF-κB signaling in CD44-expressing breast cancer
cells. Carcinogenesis. 32:1474–1483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
LaRocca TJ, Fabris F, Chen J, Benhayon D,
Zhang S, McCollum L, Schecter AD, Cheung JY, Sobie EA, Hajjar RJ,
et al: Na+/Ca2+ exchanger-1 protects against
systolic failure in the Akitains2 model of diabetic
cardiomyopathy via a CXCR4/NF-κB pathway. Am J Physiol Heart Circ
Physiol. 303:H353–H367. 2012. View Article : Google Scholar : PubMed/NCBI
|
